// App-Quantinova.ai

5083 : Indirect comparisons of triplet therapy as compared to novel hormonal therapy doublets in patients with metastatic castration sensitive prostate cancer.

Researchers

Presenter

  • Syed Arsalan Ahmed Naqvi

Principal Investigators

  • Zaryab Bin Riaz

  • Anum Riaz

  • Mahnoor Islam

  • Rabbia Siddiqi

  • Waleed Ikram

  • Muhammad Daim Bin Zafar

  • Parminder Singh

  • Irbaz Bin Riaz

  • Alan Haruo Bryce

Medical Centers

  • Mayo Clinic, Phoenix, AZ

  • Rashid Latif Medical College, Lahore, Pakistan

  • University of Arizona, Tucson, AZ

  • Dow University of Health Sciences, Karachi, Pakistan,

  • Sindh Medical College, Karachi, Pakistan

  • Department of Surgery, Mayo Clinic, Phoenix, AZ

Locations

  • United States

  • Pakistan

Companies

  • N/A

Study Components

Therapeutic Area

  • Urology

  • Oncology (ONC)

Disease

  • Prostate cancer

Biomarkers

  • N/A

Drug/Treatment

  • Docetaxel

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved